Hypoperfusion Intensity Ratio is Associated with Early Neurologic Deficit Severity and Deterioration after Mechanical Thrombectomy in Large-Vessel Occlusion Ischemic Stroke

References

1. 1.↵
   1. Mistry EA,
   2. Yeatts S,
   3. de Havenon A, et al

   . Predicting 90-day outcome after thrombectomy: baseline-adjusted 24-hour NIHSS is more powerful than NIHSS score change. Stroke 2021;52:2547–53 doi:10.1161/STROKEAHA.120.032487 pmid:34000830

   CrossRefPubMed
2. 2.↵
   1. Kniep H,
   2. Meyer L,
   3. Bechstein M, et al

   ; GSR-ET (German Stroke Registry—Endovascular Treatment). How much of the thrombectomy related improvement in functional outcome is already apparent at 24 hours and at hospital discharge? Stroke 2022;53:2828–37 doi:10.1161/STROKEAHA.121.037888 pmid:35549377

   CrossRefPubMed
3. 3.↵
   1. Zhang M,
   2. Xing P,
   3. Tang J, et al

   ; DIRECT-MT Investigators. Predictors and outcome of early neurological deterioration after endovascular thrombectomy: a secondary analysis of the DIRECT-MT trial. J Neurointerv Surg 2023;15:e9e16 doi:10.1136/neurintsurg-2022-018976 pmid:35688618

   Abstract/FREE Full Text
4. 4.↵
   1. Bhole R,
   2. Nouer SS,
   3. Tolley EA, et al

   ; COMPASS Investigators. Predictors of early neurologic deterioration (END) following stroke thrombectomy. J Neurointerv Surg 2023;15:584–88 doi:10.1136/neurintsurg-2022-018844 pmid:35584910

   Abstract/FREE Full Text
5. 5.↵
   1. Girot JB,
   2. Richard S,
   3. Gariel F, et al

   ; ETIS Investigators. Predictors of unexplained early neurological deterioration after endovascular treatment for acute ischemic stroke. Stroke 2020;51:2943–50 doi:10.1161/STROKEAHA.120.029494 pmid:32921260

   CrossRefPubMed
6. 6.↵
   1. Guenego A,
   2. Fahed R,
   3. Albers GW, et al

   . Hypoperfusion intensity ratio correlates with angiographic collaterals in acute ischaemic stroke with M1 occlusion. Eur J Neurol 2020;27:864–70 doi:10.1111/ene.14181 pmid:32068938

   CrossRefPubMed
7. 7.↵
   1. Olivot JM,
   2. Mlynash M,
   3. Inoue M, et al

   ; DEFUSE 2 Investigators. Hypoperfusion intensity ratio predicts infarct progression and functional outcome in the DEFUSE 2 Cohort. Stroke 2014;45:1018–23 doi:10.1161/STROKEAHA.113.003857 pmid:24595591

   Abstract/FREE Full Text
8. 8.↵
   1. Guenego A,
   2. Mlynash M,
   3. Christensen S, et al

   . Hypoperfusion ratio predicts infarct growth during transfer for thrombectomy. Ann Neurol 2018;84:616–20 doi:10.1002/ana.25320 pmid:30168180

   CrossRefPubMed
9. 9.↵
   1. Guenego A,
   2. Farouki Y,
   3. Mine B, et al

   . Hypoperfusion intensity ratio predicts infarct growth after successful thrombectomy for distal medium vessel occlusion. Clin Neuroradiol 2022;32:849–56 doi:10.1007/s00062-022-01141-6 pmid:35166857

   CrossRefPubMed
10. 10.↵
    1. Nomani AZ,
    2. Kamtchum Tatuene J,
    3. Rempel JL, et al

    . Association of CT-based hypoperfusion index with ischemic core enlargement in patients with medium and large vessel stroke. Neurology 2021;97:e2079–87 doi:10.1212/WNL.0000000000012855 pmid:34607925

    CrossRefPubMed
11. 11.↵
    1. Murray NM,
    2. Culbertson CJ,
    3. Wolman DN, et al

    . Hypoperfusion intensity ratio predicts malignant edema and functional outcome in large-vessel occlusive stroke with poor revascularization. Neurocrit Care 2021;35:79–86 doi:10.1007/s12028-020-01152-6

    CrossRef
12. 12.↵
    1. Winkelmeier L,
    2. Heit JJ,
    3. Adusumilli G, et al

    . Hypoperfusion intensity ratio is correlated with the risk of parenchymal hematoma after endovascular stroke treatment. Stroke 2023;54:135–43 doi:10.1161/STROKEAHA.122.040540 pmid:36416127

    CrossRefPubMed
13. 13.↵
    1. Wardlaw JM,
    2. Smith EE,
    3. Biessels GJ, et al

    ; STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013;12:822–38 doi:10.1016/S1474-4422(13)70124-8 pmid:23867200

    CrossRefPubMedWeb of Science
14. 14.↵
    1. van Swieten JC,
    2. Hijdra A,
    3. Koudstaal PJ, et al

    . Grading white matter lesions on CT and MRI: a simple scale. J Neurol Neurosurg Psychiatry 1990;53:1080–83 doi:10.1136/jnnp.53.12.1080 pmid:2292703

    Abstract/FREE Full Text
15. 15.↵
    1. Monteiro A,
    2. Makalanda HLD,
    3. Wareham J, et al

    . Mechanical thrombectomy in medium vessel occlusions using the novel aspiration Q catheters: an international multicenter experience. J Neurointerv Surg 2023 July 21. [Epub ahead of print] doi:10.1136/jnis-2022-019619 pmid:37479480

    Abstract/FREE Full Text
16. 16.↵
    1. Schulze-Zachau V,
    2. Brehm A,
    3. Ntoulias N, et al

    . Incidence and outcome of perforations during medium vessel occlusion compared with large vessel occlusion thrombectomy. J Neurointerv Surg 2023 July 21. [Epub ahead of print] doi:10.1136/jnis-2023-020531 pmid:37524518

    Abstract/FREE Full Text
17. 17.↵
    1. Pérez-García C,
    2. Moreu M,
    3. Rosati S, et al

    . Mechanical thrombectomy in medium vessel occlusions: blind exchange with mini-pinning technique versus mini stent retriever alone. Stroke 2020;51:3224–31 doi:10.1161/STROKEAHA.120.030815 pmid:33070712

    CrossRefPubMed
18. 18.↵
    1. Radu RA,
    2. Gascou G,
    3. Machi P, et al

    . Current and future trends in acute ischemic stroke treatment: direct-to-angiography suite, middle vessel occlusion, large core, and minor strokes. Eur J Radiol Open 2023;11:100536 doi:10.1016/j.ejro.2023.100536 pmid:37964786

    CrossRefPubMed
19. 19.↵
    1. Tan JC,
    2. Dillon WP,
    3. Liu S, et al

    . Systematic comparison of perfusion-CT and CT-angiography in acute stroke patients. Ann Neurol 2007;61:533–43 doi:10.1002/ana.21130 pmid:17431875

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Adams HP Jr.,
    2. Bendixen BH,
    3. Kappelle LJ, et al

    . Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 1993;24:35–41 doi:10.1161/01.str.24.1.35 pmid:7678184

    Abstract/FREE Full Text
21. 21.↵
    1. Weyland CS,
    2. Mokli Y,
    3. Vey JA, et al

    . Predictors for failure of early neurological improvement after successful thrombectomy in the anterior circulation. Stroke 2021;52:1291–98 doi:10.1161/STROKEAHA.120.030519 pmid:33626903

    CrossRefPubMed
22. 22.↵
    1. Seners P,
    2. Scheldeman L,
    3. Christensen S, et al

    ; Infarct-Growth Collaborators, Determinants of infarct core growth during inter-hospital transfer for thrombectomy. Ann Neurol 2023;93:1117–29 doi:10.1002/ana.26613 pmid:36748945

    CrossRefPubMed
23. 23.↵
    1. Mohammaden MH,
    2. Haussen DC,
    3. Pisani L, et al

    . Characterizing fast and slow progressors in anterior circulation large vessel occlusion strokes. Interv Neuroradiol 2023;29:379–85 doi:10.1177/15910199221083100 pmid:35379038

    CrossRefPubMed
24. 24.↵
    1. Seners P,
    2. Yuen N,
    3. Olivot JM, et al

    ; for Mismatch Prevalence. Factors associated with fast early infarct growth in patients with acute ischemic stroke with a large vessel occlusion. Neurology 2023;101:e2126–37 doi:10.1212/WNL.0000000000207908 pmid:37813579

    Abstract/FREE Full Text
25. 25.↵
    1. Guenego A,
    2. Marcellus DG,
    3. Martin BW, et al

    . Hypoperfusion intensity ratio is correlated with patient eligibility for thrombectomy. Stroke 2019;50:917–22 doi:10.1161/STROKEAHA.118.024134 pmid:30841821

    CrossRefPubMed
26. 26.↵
    1. Saver JL,
    2. Chapot R,
    3. Agid R, et al

    ; Distal Thrombectomy Summit Group. Thrombectomy for distal, medium vessel occlusions: a consensus statement on present knowledge and promising directions. Stroke 2020;51:2872–84 doi:10.1161/STROKEAHA.120.028956 pmid:32757757

    CrossRefPubMed
27. 27.↵
    1. Farouki Y,
    2. Bonnet T,
    3. Mine B, et al

    . First-pass effect predicts clinical outcome and infarct growth after thrombectomy for distal medium vessel occlusions. Neurosurgery 2022;91:913–19 doi:10.1227/neu.0000000000002129 pmid:36250706

    CrossRefPubMed
28. 28.↵
    1. Abdelrady M,
    2. Derraz I,
    3. Dargazanli C, et al

    . Complete recanalization predicts favorable outcome in patients with distal M2-M3 middle cerebral artery occlusions following endovascular thrombectomy. J Neuroradiol 2023;50:230–36 doi:10.1016/j.neurad.2022.11.007 pmid:36436611

    CrossRefPubMed
29. 29.↵
    1. Ospel JM,
    2. Hill MD,
    3. Kappelhof M, et al

    . Which acute ischemic stroke patients are fast progressors? Results from the ESCAPE trial control arm. Stroke 2021;52:1847–50 doi:10.1161/STROKEAHA.120.032950 pmid:33813863

    CrossRefPubMed
30. 30.↵
    1. Faizy TD,
    2. Kabiri R,
    3. Christensen S, et al

    . Distinct intra-arterial clot localization affects tissue-level collaterals and venous outflow profiles. Eur J Neurol 2021;28:4109–16 doi:10.1111/ene.15079 pmid:34424584

    CrossRefPubMed
31. 31.↵
    1. Zhang M,
    2. Zhu W,
    3. Ma Y, et al

    . Early neurological deterioration and hypoperfusion volume ratio on arterial spin labeling in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis 2021;30:105885 doi:10.1016/j.jstrokecerebrovasdis.2021.105885 pmid:34107416

    CrossRefPubMed
32. 32.↵
    1. Faizy TD,
    2. Mlynash M,
    3. Kabiri R, et al

    . Favourable arterial, tissue-level and venous collaterals correlate with early neurological improvement after successful thrombectomy treatment of acute ischaemic stroke. J Neurol Neurosurg Psychiatry 2022 May 16. [Epub ahead of print] doi:10.1136/jnnp-2021-328041 pmid:35577509

    CrossRefPubMed
33. 33.↵
    1. Bourcier R,
    2. Goyal M,
    3. Muir KW, et al

    ; HERMES Trialists Collaboration. Risk factors of unexplained early neurological deterioration after treatment for ischemic stroke due to large vessel occlusion: a post hoc analysis of the HERMES study. J Neurointerv Surg 2023;15:221–26 doi:10.1136/neurintsurg-2021-018214 pmid:35169030

    Abstract/FREE Full Text
34. 34.↵
    1. Fu J,
    2. Zhou Y,
    3. Li Q, et al

    . Perfusion changes of unexplained early neurological deterioration after reperfusion therapy. Transl Stroke Res 2020;11:195–203 doi:10.1007/s12975-019-00723-w pmid:31485869

    CrossRefPubMed
35. 35.↵
    1. Rao VL,
    2. Mlynash M,
    3. Christensen S, et al

    . Collateral status contributes to differences between observed and predicted 24-h infarct volumes in DEFUSE 3. J Cereb Blood Flow Metab 2020;40:1966–74 doi:10.1177/0271678X20918816 pmid:32423329

    CrossRefPubMed
36. 36.↵
    1. Tsui B,
    2. Chen IE,
    3. Nour M, et al

    . Perfusion collateral index versus hypoperfusion intensity ratio in assessment of collaterals in patients with acute ischemic stroke. AJNR Am J Neuroradiol 2023;44:1249–55 doi:10.3174/ajnr.A8002 pmid:37827719

    Abstract/FREE Full Text
37. 37.↵
    1. Yedavalli V,
    2. Koneru M,
    3. Hamam O, et al

    . Pretreatment CTP collateral parameters predict good outcomes in successfully recanalized middle cerebral artery distal medium vessel occlusions. Clin Neuroradiol 2023 Dec 28. [Epub ahead of print] doi:10.1007/s00062-023-01371-2 pmid:38155255

    CrossRefPubMed
38. 38.↵
    1. Nguyen TN,
    2. Qureshi MM,
    3. Strambo D, et al

    . Endovascular versus medical management of posterior cerebral artery occlusion stroke: the PLATO study. Stroke 2023;54:1708–17 doi:10.1161/STROKEAHA.123.042674 pmid:37222709

    CrossRefPubMed
39. 39.↵
    1. Pallesen LP,
    2. Lambrou D,
    3. Eskandari A, et al

    . Perfusion computed tomography in posterior circulation stroke: predictors and prognostic implications of focal hypoperfusion. Eur J Neurol 2018;25:725–31 doi:10.1111/ene.13578 pmid:29350878

    CrossRefPubMed